Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
3.170
+0.250 (8.56%)
At close: Mar 11, 2026, 4:00 PM EDT
3.135
-0.035 (-1.10%)
After-hours: Mar 11, 2026, 7:58 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $291.26 million as of March 11, 2026. Its market cap has increased by 290.53% in one year.
Market Cap
291.26M
Enterprise Value
214.46M
1-Year Change
290.53%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $291.26M, an increase of 470.78%. That is a compound annual growth rate of 48.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 268.29M | 98.64% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 278.54M |
| Ovid Therapeutics | 277.29M |
| Enlivex | 275.36M |
| Fennec Pharmaceuticals | 269.47M |
| ALX Oncology Holdings | 268.48M |
| Cibus | 268.20M |
| Inhibikase Therapeutics | 266.73M |
| Alector | 262.66M |